A Prescription for Change : How the Medicare Act Revises Hatch-Waxman to Speed Market Entry of Generic Drugs
Year of publication: |
2013
|
---|---|
Authors: | Greene, Stephanie M. |
Publisher: |
[S.l.] : SSRN |
Subject: | Markteintritt | Market entry | Generika | Generic drugs | Pharmaindustrie | Pharmaceutical industry | Gesetzliche Krankenversicherung | Public health insurance | Arzneimittel | Pharmaceuticals | Gesundheitskosten | Health care costs |
Extent: | 1 Online-Ressource (48 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | In: Journal of Corporation Law, Vol. 30, No. 2, pp. 309-355, Winter 2005 Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments October 19, 2005 erstellt |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Sustainability of pharmaceutical expenditures in the German social health care system
Hammerschmidt, Thomas, (2022)
-
Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs
Liu, Judith, (2023)
-
Sanzenbacher, Geoffrey, (2020)
- More ...
-
Protecting well known marks in China : challenges for foreign mark holders
Greene, Stephanie M., (2008)
-
Improving internal governance in unincorporated business entities : editor's corner
Greene, Stephanie M., (2009)
-
Panel session : the American Business Law Journal at fifty ; past, present, and future
Bird, Robert C., (2013)
- More ...